These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 31750988)

  • 41. Diagnostic Accuracy of Abbreviated Bi-Parametric MRI (a-bpMRI) for Prostate Cancer Detection and Screening: A Multi-Reader Study.
    Brembilla G; Giganti F; Sidhu H; Imbriaco M; Mallett S; Stabile A; Freeman A; Ahmed HU; Moore C; Emberton M; Punwani S
    Diagnostics (Basel); 2022 Jan; 12(2):. PubMed ID: 35204322
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Radiomic features from pretreatment biparametric MRI predict prostate cancer biochemical recurrence: Preliminary findings.
    Shiradkar R; Ghose S; Jambor I; Taimen P; Ettala O; Purysko AS; Madabhushi A
    J Magn Reson Imaging; 2018 Dec; 48(6):1626-1636. PubMed ID: 29734484
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prostate cancer local staging using biparametric MRI: assessment and comparison with multiparametric MRI.
    Christophe C; Montagne S; Bourrelier S; Roupret M; Barret E; Rozet F; Comperat E; Coté JF; Lucidarme O; Cussenot O; Granger B; Renard-Penna R
    Eur J Radiol; 2020 Nov; 132():109350. PubMed ID: 33080549
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Combined Analysis of Biparametric MRI and Prostate-Specific Antigen Density: Role in the Prebiopsy Diagnosis of Gleason Score 7 or Greater Prostate Cancer.
    Lee SJ; Oh YT; Jung DC; Cho NH; Choi YD; Park SY
    AJR Am J Roentgenol; 2018 Sep; 211(3):W166-W172. PubMed ID: 30016148
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Head-to-Head Comparison Between Biparametric and Multiparametric MRI for the Diagnosis of Prostate Cancer: A Systematic Review and Meta-Analysis.
    Woo S; Suh CH; Kim SY; Cho JY; Kim SH; Moon MH
    AJR Am J Roentgenol; 2018 Nov; 211(5):W226-W241. PubMed ID: 30240296
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Biparametric 3T Magnetic Resonance Imaging for prostatic cancer detection in a biopsy-naïve patient population: a further improvement of PI-RADS v2?
    Stanzione A; Imbriaco M; Cocozza S; Fusco F; Rusconi G; Nappi C; Mirone V; Mangiapia F; Brunetti A; Ragozzino A; Longo N
    Eur J Radiol; 2016 Dec; 85(12):2269-2274. PubMed ID: 27842676
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prebiopsy multiparametric 3T prostate MRI in patients with elevated PSA, normal digital rectal examination, and no previous biopsy.
    Jambor I; Kähkönen E; Taimen P; Merisaari H; Saunavaara J; Alanen K; Obsitnik B; Minn H; Lehotska V; Aronen HJ
    J Magn Reson Imaging; 2015 May; 41(5):1394-404. PubMed ID: 24956412
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A Novel Prediction Tool Based on Multiparametric Magnetic Resonance Imaging to Determine the Biopsy Strategy for Clinically Significant Prostate Cancer in Patients with PSA Levels Less than 50 ng/ml.
    He BM; Shi ZK; Li HS; Lin HZ; Yang QS; Lu JP; Sun YH; Wang HF
    Ann Surg Oncol; 2020 Apr; 27(4):1284-1295. PubMed ID: 31848822
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prediction of Prostate Cancer Risk Among Men Undergoing Combined MRI-targeted and Systematic Biopsy Using Novel Pre-biopsy Nomograms That Incorporate MRI Findings.
    Bjurlin MA; Rosenkrantz AB; Sarkar S; Lepor H; Huang WC; Huang R; Venkataraman R; Taneja SS
    Urology; 2018 Feb; 112():112-120. PubMed ID: 29155186
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Improved detection of anterior fibromuscular stroma and transition zone prostate cancer using biparametric and multiparametric MRI with MRI-targeted biopsy and MRI-US fusion guidance.
    Radtke JP; Boxler S; Kuru TH; Wolf MB; Alt CD; Popeneciu IV; Steinemann S; Huettenbrink C; Bergstraesser-Gasch C; Klein T; Kesch C; Roethke M; Becker N; Roth W; Schlemmer HP; Hohenfellner M; Hadaschik BA
    Prostate Cancer Prostatic Dis; 2015 Sep; 18(3):288-96. PubMed ID: 26078202
    [TBL] [Abstract][Full Text] [Related]  

  • 51. External Validation of the IMPROD-MRI Volumetric Model to Predict the Utility of Systematic Biopsies at the Time of Targeted Biopsy.
    Ninivaggi A; Guzzi F; Degennaro A; Ricapito A; Bettocchi C; Busetto GM; Sanguedolce F; Milillo P; Selvaggio O; Cormio L; Carrieri G; Falagario UG
    J Clin Med; 2023 Sep; 12(17):. PubMed ID: 37685815
    [No Abstract]   [Full Text] [Related]  

  • 52. The stanford prostate cancer calculator: Development and external validation of online nomograms incorporating PIRADS scores to predict clinically significant prostate cancer.
    Wang NN; Zhou SR; Chen L; Tibshirani R; Fan RE; Ghanouni P; Thong AE; To'o KJ; Ghabili K; Nix JW; Gordetsky JB; Sprenkle P; Rais-Bahrami S; Sonn GA
    Urol Oncol; 2021 Dec; 39(12):831.e19-831.e27. PubMed ID: 34247909
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Multiparametric MRI in detection and staging of prostate cancer.
    Boesen L
    Dan Med J; 2017 Feb; 64(2):. PubMed ID: 28157066
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Preoperative nomograms incorporating magnetic resonance imaging and spectroscopy for prediction of insignificant prostate cancer.
    Shukla-Dave A; Hricak H; Akin O; Yu C; Zakian KL; Udo K; Scardino PT; Eastham J; Kattan MW
    BJU Int; 2012 May; 109(9):1315-22. PubMed ID: 21933336
    [TBL] [Abstract][Full Text] [Related]  

  • 55. High Diagnostic Performance of Short Magnetic Resonance Imaging Protocols for Prostate Cancer Detection in Biopsy-naïve Men: The Next Step in Magnetic Resonance Imaging Accessibility.
    van der Leest M; Israël B; Cornel EB; Zámecnik P; Schoots IG; van der Lelij H; Padhani AR; Rovers M; van Oort I; Sedelaar M; Hulsbergen-van de Kaa C; Hannink G; Veltman J; Barentsz J
    Eur Urol; 2019 Nov; 76(5):574-581. PubMed ID: 31167748
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Using support vector machine analysis to assess PartinMR: A new prediction model for organ-confined prostate cancer.
    Wang J; Wu CJ; Bao ML; Zhang J; Shi HB; Zhang YD
    J Magn Reson Imaging; 2018 Aug; 48(2):499-506. PubMed ID: 29437268
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Developing a nomogram based on multiparametric magnetic resonance imaging for forecasting high-grade prostate cancer to reduce unnecessary biopsies within the prostate-specific antigen gray zone.
    Niu XK; Li J; Das SK; Xiong Y; Yang CB; Peng T
    BMC Med Imaging; 2017 Feb; 17(1):11. PubMed ID: 28143433
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prebiopsy Biparametric MRI for Clinically Significant Prostate Cancer Detection With PI-RADS Version 2: A Multicenter Study.
    Choi MH; Kim CK; Lee YJ; Jung SE
    AJR Am J Roentgenol; 2019 Apr; 212(4):839-846. PubMed ID: 30779662
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Stratification of aggressive prostate cancer from indolent disease-Prospective controlled trial utilizing expression of 11 genes in apparently benign tissue.
    Alinezhad S; Väänänen RM; Tallgrén T; Perez IM; Jambor I; Aronen H; Kähkönen E; Ettala O; Syvänen K; Nees M; Kallajoki M; Taimen P; Boström PJ; Pettersson K
    Urol Oncol; 2016 Jun; 34(6):255.e15-22. PubMed ID: 26857646
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prostate Cancer Differentiation and Aggressiveness: Assessment With a Radiomic-Based Model vs. PI-RADS v2.
    Chen T; Li M; Gu Y; Zhang Y; Yang S; Wei C; Wu J; Li X; Zhao W; Shen J
    J Magn Reson Imaging; 2019 Mar; 49(3):875-884. PubMed ID: 30230108
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.